ARHGAP10 is well known as a tumor suppressor and has been demonstrated in a variety of cancers, such as Uterine leiomyomas (ULs), prostate cancer, ovarian cancer (OC), lung cancer, colon carcinoma (CRC) and BC [33–38]. This evidence concerns the gene ARHGAP10 and uterine corpus leiomyoma.